CagriSema

Dual Compound. Amplified Research.

A investigational combination of Cagrilintide and Semaglutide, studied for its role in targeting two separate but complementary metabolic pathways simultaneously. Researchers are exploring how this dual-compound approach influences appetite signaling, glucose regulation, and long-term energy balance — representing a newer frontier in advanced metabolic peptide research.

Key Research Areas

•Dual amylin and GLP-1 receptor pathway research

•Appetite and satiety signaling modulation

•Synergistic glucose regulation and metabolic balance research

Third-party tested for purity and endotoxins.
Strictly for laboratory research and analytical purposes. Not for human consumption.